Reversal and relapse of hypogonadotropic hypogonadism: Resilience and fragility of the reproductive neuroendocrine system

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages 861-870

  Sidhoum, Valerie F ^a   Chan, Yee Ming ^a,b   Lippincott, Margaret F ^a   Balasubramanian, Ravikumar ^a   Quinton, Richard ^c   Plummer, Lacey ^a   Dwyer, Andrew ^a   Pitteloud, Nelly ^a   Hayes, Frances J ^a   Hall, Janet E ^a   Martin, Kathryn A ^a   Boepple, Paul A ^a   Seminara, Stephanie B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE; GONADOTROPIN; LUTEINIZING HORMONE; NEUROKININ B; SEX HORMONE;

ADULT; ANOSMIA; ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; FEMALE; FERTILITY; FGFR1 GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GNRHR GENE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; KAL1 GENE; KALLMANN SYNDROME; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; MALE; MENSTRUATION; MICROPENIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; PHENOTYPE; PRIORITY JOURNAL; PROKR2 GENE; RELAPSE; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TESTIS;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADULT; FEMALE; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; RECURRENCE; REMISSION INDUCTION; REPRODUCTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84895791491     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2809     Document Type: Article

References (53)

1. Styne DM, Grumbach MM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 12 ed. Philadelphia, PA: Elsevier Saunders; 2011:1054-1201.
2. Hoffman AR, Crowley WF Jr. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med. 1982;307:1237-1241. (Pubitemid 12001358)
3. Dodé C, Hardelin JP. Kallmann syndrome. Eur J Hum Genet. 2009; 17:139-146.
4. Whitlock KE, Illing N, Brideau NJ, Smith KM, Twomey S. Development of GnRH cells: setting the stage for puberty. Mol Cell Endocrinol. 2006;254-255:39-50. (Pubitemid 44041764)
5. Bauman A. Markedly delayed puberty or Kallmann's syndrome variant. J Androl. 1986;7:224-227. (Pubitemid 16010641)
6. Finkelstein JS, Spratt DI, O'Dea LS, et al. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men. J Clin Endocrinol Metab. 1989;69:377-385. (Pubitemid 19208466)
7. Kadva A, Di WL, Djahanbakhch O, Monson J, Silman R. Evidence for the Bauman variant in Kallmann's syndrome. Clin Endocrinol (Oxf). 1996;44:103-110. (Pubitemid 26025691)
8. Quinton R, Cheow HK, Tymms DJ, Bouloux PM, Wu FC, Jacobs HS. Kallmann's syndrome: is it always for life? Clin Endocrinol (Oxf). 1999;50:481-485. (Pubitemid 29193231)
9. Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley WF Jr, Hayes FJ. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor. J Clin Endocrinol Metab. 2001;86:2470-2475. (Pubitemid 32545694)
10. Dewailly D, Boucher A, Decanter C, Lagarde JP, Counis R, Kottler ML. Spontaneous pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-releasing hormone receptor gene. Fertil Steril. 2002;77:1288-1291. (Pubitemid 34626345)
11. Pitteloud N, Acierno JS Jr, Meysing AU, Dwyer AA, Hayes FJ, Crowley WF Jr. Reversible Kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J Clin Endocrinol Metab. 2005;90:1317-1322. (Pubitemid 40463982)
12. Ribeiro RS, Vieira TC, Abucham J. Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review. Eur J Endocrinol. 2007;156:285-290. (Pubitemid 46554494)
13. Raivio T, Falardeau J, Dwyer A, et al. Reversal of idiopathic hypogonadotropic hypogonadism. NEngl JMed. 2007;357:863-873. (Pubitemid 47347320)
14. Sinisi AA, Asci R, Bellastella G, et al. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum Reprod. 2008;23:2380-2384.
15. Gianetti E, Tusset C, Noel SD, et al. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab. 2010;95:2857-2867.
16. Tornberg J, Sykiotis GP, Keefe K, et al. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci USA. 2011;108:11524-11529.
17. Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. PLoSOne. 2012; 7:e39450.
18. Kulshreshtha B, Khadgawat R, Gupta N, Ammini A. Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism. Indian J Endocrinol Metab. 2013;17:851-854.
19. Tommiska J, Jorgensen N, Christiansen P, Juul A, Raivio T. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism. Clin Endocrinol (Oxf). 2013;78:316-317.
20. Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94:176-178. (Pubitemid 14186660)
21. Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, et al. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab. 2012;97:E136-E144.
22. Shaw ND, Seminara SB, Welt CK, et al. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011;96:E566-E576.
23. Dwyer AA, Hayes FJ, Plummer L, Pitteloud N, Crowley WF Jr. The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2010;95:4235-4243.
24. Santen RJ, Bardin CW. Episodic luteinizing hormone secretion in man: pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest. 1973;52:2617-2628.
25. Hayes FJ, McNicholl DJ, Schoenfeld D, Marsh EE, Hall JE. Free α-subunit is superior to luteinizing hormone as a marker of gonadotropin- releasing hormone despite desensitization at fast pulse frequencies. J Clin Endocrinol Metab. 1999;84:1028-1036. (Pubitemid 29138238)
26. Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley WF Jr. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab. 2001;86:53-58. (Pubitemid 32109775)
27. Exome Variant Server. NHLBI GO Exome Sequencing Project (ESP). Seattle, WA.
28. Raivio T, Sidis Y, Plummer L, et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2009; 94:4380-4390.
29. Bedecarrats GY, Linher KD, Kaiser UB. Two common naturally occurring mutations in the human gonadotropin-releasing hormone (GnRH) receptor have differential effects on gonadotropin gene expression and on GnRH-mediated signal transduction. J Clin Endocrinol Metab. 2003;88:834-843. (Pubitemid 36207830)
30. Cole LW, Sidis Y, Zhang C, et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab. 2008;93:3551-3559.
31. González-Perez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88:440-449.
32. Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet. 2001; 10:591-597. (Pubitemid 32229363)
33. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812-3814. (Pubitemid 37442253)
34. Ferrer-Costa C, Gelpí JL, Zamakola L, Parraga I, de la Cruz X, Orozco M. PMUT:a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics. 2005;21:3176-3178. (Pubitemid 41418475)
35. Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. Mutation- Taster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575-576.
36. Pitteloud N, Hayes FJ, Boepple PA, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002; 87:152-160. (Pubitemid 34084685)
37. Gianetti E, Hall JE, Au MG, et al. When genetic load does not correlate with phenotypic spectrum: lessons from the GnRH receptor (GNRHR). J Clin Endocrinol Metab. 2012;97:E1798-E1807.
38. Seminara SB, Hayes FJ, Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev. 1998;19:521-539. (Pubitemid 28467709)
39. Spratt DI, Carr DB, Merriam GR, Scully RE, Rao PN, Crowley WF Jr. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab. 1987;64:283-291. (Pubitemid 17001060)
40. Moya-Plana A, Villanueva C, Laccourreye O, Bonfils P, De Roux N. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency. Eur J Endocrinol. 2012;168(1):31-37.
41. Whitlock KE. Origin and development of GnRH neurons. Trends Endocrinol Metab. 2005;16:145-151. (Pubitemid 40603093)
42. Lee DA, Bedont JL, Pak T, et al. Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche. Nat Neurosci. 2012;15:700-702.
43. Silverman AJ, Gibson M. Hypothalamic transplantation repair of reproductive defects in hypogonadal mice. Trends Endocrinol Metab. 1990;1:403-408.
44. Herbison AE, Porteous R, Pape JR, Mora JM, Hurst PR. Gonadotropin- releasing hormone neuron requirements for puberty, ovulation, and fertility. Endocrinology. 2008;149:597-604. (Pubitemid 351159348)
45. Costa-Barbosa FA, Balasubramanian R, Keefe KW, et al. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab. 2013;98:E943-E953.
46. Oliveira LM, Seminara SB, Beranova M, et al. The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab. 2001;86:1532-1538. (Pubitemid 32374899)
47. Beranova M, Oliveira LM, Bédécarrats GY, et al. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2001;86:1580-1588. (Pubitemid 32374907)
48. Santhakumar A, Balasubramaniam R, Miller M, Quinton R. Reversal of Isolated Hypogonadotropic Hypogonadism: long-term integrity of hypothalamopituitary-testicular axis in two men is dependent on intermittent androgen exposure. Clin Endocrinol (Oxf). 2013.
49. Rose RM, Bourne PG, Poe RO, Mougey EH, Collins DR, Mason JW. Androgen responses to stress. II. Excretion of testosterone, epitestosterone, androsterone and etiocholanolone during basic combat training and under threat of attack. Psychosom Med. 1969;31: 418-436.
50. Kreuz LE, Rose RM, Jennings JR. Suppression of plasma testosterone levels and psychological stress. A longitudinal study of young men in Officer Candidate School. Arch Gen Psychiatry. 1972;26:479-482.
51. Schweiger U, Deuschle M, Weber B, et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med. 1999;61:292-296. (Pubitemid 29249785)
52. Strauss RH, Lanese RR, Malarkey WB. Weight loss in amateur wrestlers and its effect on serum testosterone levels. JAMA. 1985; 254:3337-3338. (Pubitemid 16146577)
53. Hall JE. Neuroendocrine control of the menstrual cycle. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's Reproductive Endocrinology. 6th ed. Philadelphia, PA: Elsevier Saunders; 2009:139-154.